MUTABILITY AND RELATIONSHIP BETWEEN POSITIVE AND NEGATIVE SYMPTOMS DURING NEUROLEPTIC TREATMENT IN SCHIZOPHRENIA

被引：47

作者：

TANDON, R

GOLDMAN, RS

GOODSON, JA

GREDEN, JF

机构：

[1] Schizophrenia Program, University of Michigan Medical Center, Ann Arbor, MI

来源：

关键词：

D O I：

10.1016/0006-3223(90)90502-S

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

[No abstract available]

引用

页码：1323 / 1326

页数：4

共 18 条

[1]

Andreasen, 1984, SCALE ASSESSMENT POS

[2]

ANDREASEN NC, 1982, AM J PSYCHIAT, V139, P297

ANGRIST, B ;

ROTROSEN, J ;

GERSHON, S .

[4]

BREIER A, 1987, AM J PSYCHIAT, V144, P1549

[5]

COLE JO, 1966, PSYCHIATRIC DRUGS, P153

[6]

CROW TJ, 1980, BRIT MED J, V280, P1

[7]

ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837

[8]

JOHNSTONE EC, 1978, LANCET, V1, P848

[9]

KAY SR, 1989, ARCH GEN PSYCHIAT, V46, P711

[10]

Meltzer H.Y., 1985, CONTROVERSIES SCHIZO, P110